www.xinhuanet.com
XINHUA online
CHINA VIEW
VIEW CHINA
 Breaking News Bush security investigates possible grenade incident     US Senate approves Iraq war funds      Canadian government not to resign despite losing censure vote     Egyptian parliament passes constitutional amendment    First South American-Arab summit opens      Russia, EU reach accord on closer relations     
Home  
China  
World  
Business  
Technology  
Opinion  
Culture/Edu  
Sports  
Entertainment  
Life/Health  
Travel  
Weather  
  About China
  Map
  History
  Constitution
  CPC & Other Parties
  State Organs
  Local Leadership
  White Papers
  Statistics
  Major Projects
  English Websites
  BizChina
- Conferences & Exhibitions
- Investment
- Bidding
- Enterprises
- Policy update
- Technological & Economic Development Zones
Source Manufacturers and Suppliers from China and around the world
   News Photos Voice People BizChina Feature About us   
Susilo says Soeharto deserves respect
www.chinaview.cn 2005-05-10 19:46:17

    JAKARTA, May 10 (Xinhuanet) -- Indonesian President Susilo Bambang Yudhoyono said Tuesday long-serving president Soeharto, who is under hospital treatment, deserved his respect, declining to comment on possible resumption of Soeharto's graft trial.

    "It's not the right time to ask that question," Susilo responded to a journalist question over Soeharto's graft trial shortly after paying a visit to Soeharto at the Partamina Hospital here.

    Susilo said he visited Soeharto because he has a moral obligation to show respect to the past leaders.

    "The government also has an obligation to send the presidentialmedical team to treat him (Soeharto). Such a special treatment applies to all former presidents and vice presidents," he said.

    Soeharto was sent to hospital Sunday for intestinal bleeding.

    The 83-year-old man ruled Indonesia for 32 years but was forced to resign in nationwide pro-democracy protests in 1998. He was charged with corruption but the Jakarta court ruled in 2000 that Soeharto was medically unfit for trial. Enditem

    

  Related Story
Copyright ©2003 Xinhua News Agency. All rights reserved.
Reproduction in whole or in part without permission is prohibited.